Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Issues Mixed Outlook
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $87.84 -0.46%
Revenue Growth %: +8.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +8.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.22, $0.10 better than the analyst estimate of $1.12. Revenue for the quarter came in at $938 million versus the consensus estimate of $932.25 million.
GUIDANCE:
Edwards Lifesciences sees FY2018 EPS of $4.50-$4.70, versus the consensus of $4.54.
Edwards Lifesciences sees FY2018 EPS of $1.05-$1.15, versus the consensus of $1.17.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
